Steven H. Holtzman

Director, ANADYS PHARMACEUTICALS INC.

Companies

Camp4 Therapeutics CorpBoard member Oct 10, 2024 to now¹
BiogenEVP Corp Devel and Strategy Jan 11, 2011 to Feb 25, 2016²
INFINITY PHARMACEUTICALS, INC.Board member Sep 13, 2006 to Jun 4, 2012³
INFINITY PHARMACEUTICALS, INC.Chair Sep 18, 2007 to Dec 13, 2010⁴
INFINITY PHARMACEUTICALS, INC.Chief executive officer Sep 13, 2006 to Jan 7, 2009³
INFINITY PHARMACEUTICALS, INC.President Dec 14, 2007 to Aug 29, 2008⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Camp4 Therapeutics Corp CAMP108,946 shares⁶$346.4K at $3.18Oct 15, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Oct 15, 2024Converted 8,917 shares of Camp4 Therapeutics Corp⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARCamp4 Therapeutics Corp, Board member
2
SEC EDGARBiogen, EVP Corp Devel and Strategy
3
SEC EDGARINFINITY PHARMACEUTICALS, INC., Board member
4
SEC EDGARINFINITY PHARMACEUTICALS, INC., Chair
5
SEC EDGARINFINITY PHARMACEUTICALS, INC., President
6
SEC EDGARCamp4 Therapeutics Corp shares after the filing of Oct 15, 2024